A. Clark

发表

Diagnosis and management of chronic graft‐versus‐host disease

J. Scarisbrick, F. Dignan, P. Amrolia, 2012, British journal of haematology.

Organ‐specific management and supportive care in chronic graft‐versus‐host disease

J. Scarisbrick, F. Fortune, F. Dignan, 2012, British journal of haematology.

BCSH/BSBMT Guideline: Diagnosis and Management of Chronic Graft- versus-Host Disease

F. Dignan, P. Amrolia, A. Clark, 2012 .

BCSH/BSBMT Guideline: Organ-Specific Management and Supportive Care in Chronic Graft-versus -Host Disease

F. Fortune, A. Clark, G. Jackson, 2012 .

BCSH/BSBMT/UK clinical virology network guideline: diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation

F. Dignan, A. Clark, B. Shaw, 2016, British journal of haematology.

Lipid preparations of amphotericin for the treatment of fungal infections

A. Clark, I. Franklin, 1999, British journal of haematology.

Allo-HSCT in transplant-naïve patients with Hodgkin lymphoma: a single-arm, multicenter study.

N. Russell, I. Kayani, S. Mackinnon, 2019, Blood advances.

Viral infections The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation

A. Clark, A. Oakhill, D. Carrington, 2002 .

The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation

A. Clark, A. Oakhill, D. Carrington, 2002, Bone Marrow Transplantation.

Diagnosis and management of acute graft‐versus‐host disease

J. Scarisbrick, F. Dignan, P. Amrolia, 2012, British journal of haematology.

Management of cytomegalovirus infection in haemopoietic stem cell transplantation

K. Peggs, V. Emery, A. Clark, 2013, British journal of haematology.

Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party

C. Craddock, M. Labopin, A. Nagler, 2022, Bone Marrow Transplantation.

Impact of graft‐versus‐lymphoma effect on outcomes after reduced intensity conditioned‐alemtuzumab allogeneic haematopoietic stem cell transplantation for patients with mature lymphoid malignancies

C. Craddock, J. Ward, R. Malladi, 2018, British Journal of Haematology.

Impact of ABO blood group mismatch in alemtuzumab-based reduced-intensity conditioned haematopoietic SCT

J. Ward, R. Malladi, A. Clark, 2015, Bone Marrow Transplantation.

Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution.

A. Pettitt, C. Crawley, J. Snowden, 2010, Blood.

Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants

S Mackinnon, N H Russell, J A Madrigal, 2017, Bone Marrow Transplantation.

Title : Recipient / Donor HLA and CMV matching in recipients of T cell depleted 1 unrelated donor haematopoietic cell transplants 2 3 4 Short title : Donor factors in transplant outcome 5 6

S. Mackinnon, J. Madrigal, A. Clark, 2016 .

P. Griffiths, H. Prentice, A. Clark, 1999, British journal of haematology.

Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: an update on cord blood unit selection, donor selection algorithms and conditioning protocols

C. Craddock, C. Crawley, N. Russell, 2016, British journal of haematology.

C. Craddock, N. Russell, J. Snowden, 2016, British journal of haematology.

Patient/Donor CMV Matching Is a Critical Determinant of Survival in Unrelated Donor Haematopoietic Stem Cell Transplantation

N. Russell, S. Mackinnon, J. Madrigal, 2014 .

Isolation and therapeutic potential of human haemopoietic stem cells

T. Holyoake, A. Clark, J. Mountford, 2003, Cytotechnology.

The evolving management of a rare lymphoproliferative disorder–T‐cell prolymphocytic leukemia

A. Clark, P. Gallipoli, M. Leach, 2009, American journal of hematology.

Better HLA Matching as Revealed Only by Next Generation Sequencing Technology Results in Superior Overall Survival Post-Allogeneic Haematopoietic Cell Transplantation with Unrelated Donors

N. Russell, S. Mackinnon, J. Madrigal, 2018 .

Dose escalation therapy in previously untreated patients with multiple myeloma following Z‐Dex induction treatment

G. Cook, A. Clark, K. Douglas, 2002, British journal of haematology.

Ideal body weight correlates better with engraftment after PBSC autograft than actual body weight, but is under-estimated in myeloma patients possibly due to disease-related height loss

P. MacLean, A. Clark, K. Douglas, 2007, Bone Marrow Transplantation.

Allogeneic stem cell transplantation for chronic myeloid leukaemia is safe and effective in high risk patients following second generation tyrosine kinase inhibitors: A single centre's experience.

M. Copland, A. Clark, A. Parker, 2013, Leukemia research reports.

Ecstasy-induced very severe aplastic anaemia complicated by invasive pulmonary mucormycosis treated with allogeneic peripheral blood progenitor cell transplant.

A. Clark, N. Butt, 1997, Clinical and laboratory haematology.